Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Mittereder

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Oncogene|July 1, 1989
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exonE Brownell, N Mittereder, N R Rice
Journal of Virology|November 1, 1996
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapyN Mittereder, K L March, B C Trapnell
Gene Therapy|May 1, 1994
Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lungS Yei, N Mittereder, K Tang, et al.
Virology|July 1, 1993
Factors affecting retroviral vector function and structural integrityJ R McLachlin, N Mittereder, M B Daucher, et al.
Human Gene Therapy|June 1, 1994
In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungS Yei, N Mittereder, S Wert, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 31, 2002
Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularizationE J Su, C L Cioffi, S Stefansson, et al.
Human Gene Therapy|June 1, 1994
Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNAN Mittereder, S Yei, C Bachurski, et al.
Cancer Gene Therapy|June 1, 1995
Transduction of normal and malignant oral epithelium by an adenovirus vector: the effect of dose and treatment time on transduction efficiency and tissue penetrationG L Clayman, B C Trapnell, N Mittereder, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Oncogene|July 1, 1989
A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exonE Brownell, N Mittereder, N R Rice
Journal of Virology|November 1, 1996
Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapyN Mittereder, K L March, B C Trapnell
Gene Therapy|May 1, 1994
Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lungS Yei, N Mittereder, K Tang, et al.
Virology|July 1, 1993
Factors affecting retroviral vector function and structural integrityJ R McLachlin, N Mittereder, M B Daucher, et al.
Human Gene Therapy|June 1, 1994
In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lungS Yei, N Mittereder, S Wert, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 31, 2002
Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularizationE J Su, C L Cioffi, S Stefansson, et al.
Human Gene Therapy|June 1, 1994
Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNAN Mittereder, S Yei, C Bachurski, et al.
Cancer Gene Therapy|June 1, 1995
Transduction of normal and malignant oral epithelium by an adenovirus vector: the effect of dose and treatment time on transduction efficiency and tissue penetrationG L Clayman, B C Trapnell, N Mittereder, et al.
Pageof 1